Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis

Journal of Neuroimmunology

Volumn 105, Issue 1, 2000, Pages 96-101

  Feakes, Robert ^a   Sawcer, Stephen ^a   Broadley, Simon ^a   Coraddu, Francesca ^a   Roxburgh, Richard ^a   Gray, Julia ^a   Clayton, David ^b   Compston, Alastair ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Association; Interleukin 1 receptor antagonist; Linkage disequilibrium; Multiple sclerosis; SNP; VNTR

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ALLELE; ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; FEMALE; HAPLOTYPES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LINKAGE DISEQUILIBRIUM; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; SIALOGLYCOPROTEINS; TANDEM REPEAT SEQUENCES;

EID: 0034212944     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00203-4     Document Type: Article

References (34)

1. Arend W.P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest. 88:1991;1445-1451.
2. Bioque G., Crusius J.B., Koutroubakis I., Bouma G., Kostense P.J., Meuwissen S.G., Pena A.S. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin. Exp. Immunol. 102:1995;379-383.
3. Clay F.E., Tarlow J.K., Cork M.J., Cox A., Nicklin M.J., Duff G.W. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum. Genet. 97:1996;723-726.
4. Compston A., Ebers G., Lassmann H., McDonald I., Matthews B., Wekerle H. Mcalpine's Multiple Sclerosis. 1998;Churchill Livingstone, London.
5. Cork M.J., Tarlow J.K., Blakemore A., Mee J.B., Crane A.M., Stierle C., Bleehen S.S., Duff G.W. Psoriasis and interleukin-1. A translation. J. R. Coll. Phys. Lond. 27:1993;366.
6. Cox A., Camp N.J., Nicklin M.J., diGiovine F.S., Duff G.W. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am. J. Hum. Genet. 62:1998;1180-1188.
7. Crusius J.B., Pena A.S., VanOosten B.W., Bioque G., Garcia A., Dijkstra C.D., Polman C.H. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet. 346:1995;979-980.
8. Danis V.A., Millington M., Hyland V.J., Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Immunol. 99:1995;303-310.
9. DeLaConcha E.G., Arroyo R., Crusius J.B., Campillo J.A., Martin C., VarelaDeSeijas E., Pena A.S., Claveria L.E., Fernandez-Arquero M. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J. Neuroimmunol. 80:1997;172-178.
10. Devlin B., Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 29:1995;311-322.
11. diGiovine F.S., Takhsh E., Blakemore A.I., Duff G.W. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum. Mol. Genet. 1:1992;450.
12. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood. 77:1991;1627-1652.
13. Epplen C., Jackel S., Santos E.J.M., D'Souza M., Poehlau D., Dotzauer B., Sindern E., Haupts M., Rude K.P., Weber F., Stover J., Poser S., Gehler W., Malin J.P., Przuntek H., Epplen J.T. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann. Neurol. 41:1997;341-352.
14. Guasch J.F., Bertina R.M., Reitsma P.H. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. Cytokine. 8:1996;598-602.
15. Huang W.X., He B., Hillert J. An interleukin 1-receptor-antagonist gene polymorphism is not associated with multiple sclerosis. J. Neuroimmunol. 67:1996;143-144.
16. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat. Genet. 22:1999;139-144.
17. Kruglyak L., Daly M.J., Reeve-Daly M.P., Lander E.S. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am. J. Hum. Genet. 58:1996;1347-1363.
18. Mann C.L.A., Davies M.B., Boggild M., Jones P.W., Fryer A.A., Strange R.C., Hawkins C.P. Polymorphisms at the IL-1RN and IL-1beta loci influence disability in multiple sclerosis. Multiple Sclerosis. 4:1998;S34.
19. Mansfield J.C., Holden H., Tarlow J.K., DiGiovine F.S., McDowell T.L., Wilson A.G., Holdsworth C.D., Duff G.W. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology. 106:1994;637-642.
20. Martin D., Near S.L. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 61:1995;241-245.
21. Nicklin M.J., Weith A., Duff G.W. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics. 19:1994;382-384.
22. Nicoletti F., Patti F., DiMarco R., Zaccone P., Nicoletti A., Meroni P., Reggio A. Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment. Cytokine. 8:1996;395-400.
23. Pociot F., Molvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 22:1992;396-402.
24. Poser C.M., Paty D.W., Scheinberg L., McDonald I.w., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
25. Risch N., Merikangas K. Genetic analysis of complex diseases. Science. 275:1997;1329-1330.
26. Schneider S., Kueffer J.M., Roessli D., Excoffier L. Arlequin Ver. 1.1: A Software For Population Genetic Data Analysis. 1997;Genetics and Biometry Laboratory, University of Geneva.
27. Schrijver H.M., Crusius J.B., Uitdehaag B.M., GarciaGonzalez M.A., Kostense P.J., Polman C.H., Pena A.S. Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology. 52:1999;595-599.
28. Sciacca F.L., Ferri C., Vandenbroeck K., Veglia F., Gobbi C., Martinelli F., Franciotta D., Zaffaroni M., Marrosu M., Martino G., Martinelli V., Comi G., Canal N., Grimaldi L.M. Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients. Neurology. 52:1999;1896-1898.
29. Semana G., Yaouanq J., Alizadeh M., Clanet M., Edan G. Interleukin-1 receptor antagonist gene in multiple sclerosis. Lancet. 349:1997;476.
30. Spielman R.S., Ewens W.J. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59:1996;983-989.
31. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
32. Tarlow J.K., Blakemore A.I., Lennard A., Solari R., Hughes H.N., Steinkasserer A., Duff G.W. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet. 91:1993;403-404.
33. Voltz R., Hartmann M., Spuler S., Scheller A., Mai N., Hohlfeld R., Yousry T. Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist. J. Neurol. Neurosurg. Psych. 62:1997;200-201.
34. Wansen K., Pastinen T., Kuokkanen S., Wikstrom J., Palo J., Peltonen L., Tienari P. Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCR beta, IGH, IFN-gamma and IL-1nra/IL-1 beta loci. J. Neuroimmunol. 79:1997;29-36.